More about

Metformin

News
June 03, 2024
2 min read
Save

Metformin associated with fewer hospitalizations in children with asthma

Metformin associated with fewer hospitalizations in children with asthma

SAN DIEGO — Children with asthma who used metformin experienced decreases in asthma-related hospitalizations and oral steroid use, according to an abstract presented at the American Thoracic Society International Conference.

News
May 17, 2024
2 min read
Save

Metformin use linked to lower risk for rare blood cancer

Metformin use linked to lower risk for rare blood cancer

Individuals prescribed the antidiabetes treatment metformin less likely developed a myeloproliferative neoplasm —potentially also reducing a person’s chances for developing certain cancers — according to data published in Blood Advances.

News
March 22, 2024
4 min read
Save

Metformin may reduce risk for overall cancer, GI malignancies, meta-analysis shows

Metformin may reduce risk for overall cancer, GI malignancies, meta-analysis shows

The commonly used diabetes drug metformin may reduce risk for cancer, according to study results published in Journal of the National Cancer Institute.

News
March 04, 2024
3 min read
Save

More studies needed to assess effects of inositol on PCOS outcomes

More studies needed to assess effects of inositol on PCOS outcomes

Findings on the use of inositol for managing polycystic ovary syndrome are inconclusive, with results varying based on therapy, trial design and outcomes reported, according to a systematic review and meta-analysis.

News
December 12, 2023
2 min watch
Save

VIDEO: Metformin may have beneficial effect on AMD progression

VIDEO: Metformin may have beneficial effect on AMD progression

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Albert Augustin, MD, speaks about the beneficial effects of metformin on age-related macular degeneration.

News
December 07, 2023
2 min read
Save

GLP-1 receptor agonists may protect against CRC in patients with type 2 diabetes

GLP-1 receptor agonists may protect against CRC in patients with type 2 diabetes

Glucagon-like peptide 1 receptor agonists were associated with a reduced risk for colorectal cancer among patients with type 2 diabetes, regardless of weight status, compared with other antidiabetics, according to research.

News
November 14, 2023
2 min read
Save

SGLT2 inhibitors ‘substantially’ reduce gout risk in patients with type 2 diabetes

SGLT2 inhibitors ‘substantially’ reduce gout risk in patients with type 2 diabetes

SAN DIEGO — Sodium-glucose cotransporter-2 inhibition may reduce the risk for gout by as much as 40% to 60% among certain patients with type 2 diabetes treated with metformin, according to data presented at ACR Convergence 2023.

News
November 02, 2023
3 min read
Save

Severe anion gap metabolic acidosis in a patient with type 2 diabetes

Severe anion gap metabolic acidosis in a patient with type 2 diabetes

A man aged 51 years with a history of alcohol use disorder and type 2 diabetes treated with metformin and glimepiride and alcohol presented to the hospital for a witnessed cardiac arrest at home.

News
October 17, 2023
2 min read
Save

Weight loss with anti-obesity medications comparable for older, younger adults

Weight loss with anti-obesity medications comparable for older, younger adults

DALLAS — Older adults who received anti-obesity medications lost a similar amount of weight at 3 to 5 years as younger adults, with no increased side effects, according to research presented at ObesityWeek.

News
October 04, 2023
3 min read
Save

Metformin provides glycemic, neonatal benefits for women with gestational diabetes

Metformin provides glycemic, neonatal benefits for women with gestational diabetes

Metformin may lengthen the time until insulin initiation, lower fasting glucose and improve neonatal outcomes for pregnant women with gestational diabetes, according to data from a randomized trial.

View more